A screening test for slow metabolisers of tolbutamide

scientific article

A screening test for slow metabolisers of tolbutamide is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2125.1991.TB05587.X
P8608Fatcat IDrelease_hiw7q46ajveytoypjldiw5qove
P932PMC publication ID1368574
P698PubMed publication ID1867959
P5875ResearchGate publication ID21287944

P2093author name stringPage MA
Shenfield GM
Boutagy JS
P2860cites workCharacterization of the common genetic defect in humans deficient in debrisoquine metabolismQ34049056
Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiaeQ35877286
The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal lociQ38618586
Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamilyQ41750193
Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizersQ41904363
Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indicesQ42250442
Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidationsQ44696228
Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitusQ51665590
Pharmacogenetics of tolbutamide metabolism in humansQ67017361
Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamideQ68411894
Lack of relationship between tolbutamide metabolism and debrisoquine oxidation phenotypeQ68687397
Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo dispositionQ69066656
Drug absorption, metabolism, and excretion. IX. Some new aspects of pharmacokinetics on tolbutamide in rabbitsQ69615550
Normal metabolism of debrisoquine and theophylline in a slow tolbutamide metaboliserQ69848110
The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide eliminationQ70426611
Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in manQ70644714
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)649-654
P577publication date1991-06-01
P1433published inBritish Journal of Clinical PharmacologyQ176044
P1476titleA screening test for slow metabolisers of tolbutamide
P478volume31